Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
11 hedge funds and large institutions have $1.17M invested in Biostar Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
13% more capital invested
Capital invested by funds: $1.04M → $1.17M (+$135K)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$70K |
| 2 |
Renaissance Technologies
New York
|
+$49.3K |
| 3 |
Two Sigma Investments
New York
|
+$15.9K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$1.88K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$26.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 3 |
Jane Street
New York
|
-$17.8K |
| 4 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$17K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $957K | +$49.3K | +4,429 | +6% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $71K | +$70K | +6,286 | New |
|
|
SIM
3
Spark Investment Management
New York
| $40K | -$26.1K | -2,343 | -40% |
|
|
EGA
4
Eagle Global Advisors
Houston,
Texas
| $33K | -$15.3K | -1,376 | -32% |
|
5
California Public Employees Retirement System
Sacramento,
California
| $23K | – | – | – |
|
|
6
Jane Street
New York
| $21K | -$17.8K | -1,598 | -46% |
|
|
7
Two Sigma Investments
New York
| $16K | +$15.9K | +1,429 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5K | +$1.11K | +100 | +28% |
|
|
U
9
UBS
Zurich,
Switzerland
| $3K | +$1.88K | +169 | +142% |
|
10
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$22K | -2,157 | Closed |
|
|
AL
12
Airain Ltd
St. Peter Port,
Guernsey
| – | -$17K | -1,716 | Closed |
|
|
VKH
13
Virtu KCG Holdings
New York
| – | -$16K | -1,568 | Closed |
|
14
Morgan Stanley
New York
| – | +$11 | +1 | +4% |
|
BSPM Hedge Fund Activity: Q3 2014 in Review
11 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q3 2014, worth a combined $1.17M — up 13% from $1.04M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BSPM and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $70K. The largest seller was Spark Investment Management, cutting an estimated $26.1K.
- 11 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q3 2014, down from 13 in Q2 2014.
- Funds reported $1.17M of Biostar Pharmaceuticals, Inc. stock for Q3 2014, up 13% quarter-over-quarter.
- 2 funds opened new Biostar Pharmaceuticals, Inc. positions in Q3 2014 and 4 closed out, a net change of -2 holders.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q3 2014 was Bridgeway Capital Management, an estimated $70K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q3 2014 was Spark Investment Management, an estimated $26.1K sold.
Based on aggregated 13F filings for Q3 2014.